Clinical Trial Update: Choroidal Response to Novel Spectacle Lens to Control Myopia Progression [NA]

View source ↗

Summary

An update on a clinical trial evaluating a novel spectacle lens from SightGlass Vision to slow myopia progression; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Novel Spectacle Lens (SightGlass Vision)

Snippet

Sponsor: SightGlass Vision, Inc. | Conditions: Myopia, Progressive | NA | Status: ACTIVE_NOT_RECRUITING